78 related articles for article (PubMed ID: 24504051)
1. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
[TBL] [Abstract][Full Text] [Related]
2. ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling.
Bock J; Mochmann LH; Schlee C; Farhadi-Sartangi N; Göllner S; Müller-Tidow C; Baldus CD
PLoS One; 2013; 8(1):e52872. PubMed ID: 23300998
[TBL] [Abstract][Full Text] [Related]
3. AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair.
Ford JB; Baturin D; Burleson TM; Van Linden AA; Kim YM; Porter CC
Oncotarget; 2015 Sep; 6(29):28001-10. PubMed ID: 26334102
[TBL] [Abstract][Full Text] [Related]
4. PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.
Ariës IM; Bodaar K; Karim SA; Chonghaile TN; Hinze L; Burns MA; Pfirrmann M; Degar J; Landrigan JT; Balbach S; Peirs S; Menten B; Isenhart R; Stevenson KE; Neuberg DS; Devidas M; Loh ML; Hunger SP; Teachey DT; Rabin KR; Winter SS; Dunsmore KP; Wood BL; Silverman LB; Sallan SE; Van Vlierberghe P; Orkin SH; Knoechel B; Letai AG; Gutierrez A
J Exp Med; 2018 Dec; 215(12):3094-3114. PubMed ID: 30404791
[TBL] [Abstract][Full Text] [Related]
5. EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.
Zhou Y; Petrovic J; Zhao J; Zhang W; Bigdeli A; Zhang Z; Berger SL; Pear WS; Faryabi RB
Mol Cell; 2022 Mar; 82(5):1003-1020.e15. PubMed ID: 35182476
[TBL] [Abstract][Full Text] [Related]
6. EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21)
Buteyn NJ; Burke CG; Sartori VJ; Deering-Gardner E; DeBruine ZJ; Kamarudin D; Chandler DP; Monovich AC; Perez MW; Yi JS; Ries RE; Alonzo TA; Ryan RJ; Meshinchi S; Triche TJ
bioRxiv; 2024 May; ():. PubMed ID: 38798454
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias.
Tursky ML; Beck D; Thoms JA; Huang Y; Kumari A; Unnikrishnan A; Knezevic K; Evans K; Richards LA; Lee E; Morris J; Goldberg L; Izraeli S; Wong JW; Olivier J; Lock RB; MacKenzie KL; Pimanda JE
Leukemia; 2015 Apr; 29(4):819-27. PubMed ID: 25306899
[TBL] [Abstract][Full Text] [Related]
8. The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
Balakrishnan K; Peluso M; Fu M; Rosin NY; Burger JA; Wierda WG; Keating MJ; Faia K; O'Brien S; Kutok JL; Gandhi V
Leukemia; 2015 Sep; 29(9):1811-22. PubMed ID: 25917267
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Reinisch A; Etchart N; Thomas D; Hofmann NA; Fruehwirth M; Sinha S; Chan CK; Senarath-Yapa K; Seo EY; Wearda T; Hartwig UF; Beham-Schmid C; Trajanoski S; Lin Q; Wagner W; Dullin C; Alves F; Andreeff M; Weissman IL; Longaker MT; Schallmoser K; Majeti R; Strunk D
Blood; 2015 Jan; 125(2):249-60. PubMed ID: 25406351
[TBL] [Abstract][Full Text] [Related]
10. Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.
Wang S; Kollipara RK; Srivastava N; Li R; Ravindranathan P; Hernandez E; Freeman E; Humphries CG; Kapur P; Lotan Y; Fazli L; Gleave ME; Plymate SR; Raj GV; Hsieh JT; Kittler R
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4251-6. PubMed ID: 24591637
[TBL] [Abstract][Full Text] [Related]
11. miR-4482 and miR-3912 aim for 3'UTR of ERG mRNA in prostate cancer.
Mumtaz S; Usman Rashid M; Khan RU; Malkani N
PLoS One; 2023; 18(6):e0286996. PubMed ID: 37310937
[TBL] [Abstract][Full Text] [Related]
12. Pipeline for characterizing alternative mechanisms (PCAM) based on bi-clustering to study colorectal cancer heterogeneity.
Cao S; Chang W; Wan C; Lu X; Dang P; Zhou X; Zhu H; Chen J; Li B; Zang Y; Wang Y; Zhang C
Comput Struct Biotechnol J; 2023; 21():2160-2171. PubMed ID: 37013005
[TBL] [Abstract][Full Text] [Related]
13. FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling.
Liebig S; Neumann M; Silva P; Ortiz-Tanchez J; Schulze V; Isaakidis K; Schlee C; Schroeder MP; Beder T; Morris LGT; Chan TA; Bastian L; Burmeister T; Schwartz S; Gökbuget N; Mochmann LH; Baldus CD
Sci Rep; 2023 Jan; 13(1):972. PubMed ID: 36653435
[TBL] [Abstract][Full Text] [Related]
14. ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.
Wen X; Chen S; Chen X; Qiu H; Wang W; Zhang N; Liu W; Wang T; Ding X; Zhang L
Front Oncol; 2022; 12():887068. PubMed ID: 36249018
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
Sun ZP; Tan ZG; Peng C; Yi WM
J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
[TBL] [Abstract][Full Text] [Related]
16. MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion.
Chen B; Yuan Y; Sun L; Chen J; Yang M; Yin Y; Xu Y
Front Cell Dev Biol; 2020; 8():832. PubMed ID: 32984327
[TBL] [Abstract][Full Text] [Related]
17. Comparative RNA-seq analysis reveals dys-regulation of major canonical pathways in ERG-inducible LNCaP cell progression model of prostate cancer.
Kumar P; Chakraborty J; Sukumar G; Dalgard C; Chatterjee R; Biswas R
Oncotarget; 2019 Jul; 10(42):4290-4306. PubMed ID: 31303963
[TBL] [Abstract][Full Text] [Related]
18. The oncogenic transcription factor ERG represses the transcription of the tumour suppressor gene
Adamo P; Porazinski S; Rajatileka S; Jumbe S; Hagen R; Cheung MK; Wilson I; Ladomery MR
Oncol Lett; 2017 Nov; 14(5):5605-5610. PubMed ID: 29113189
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.
Shang L; Ye X; Zhu G; Su H; Su Z; Chen B; Xiao K; Li L; Peng M; Peng T
Oncotarget; 2017 Sep; 8(44):76816-76831. PubMed ID: 29100351
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
Lemma SA; Kuusisto M; Haapasaari KM; Sormunen R; Lehtinen T; Klaavuniemi T; Eray M; Jantunen E; Soini Y; Vasala K; Böhm J; Salokorpi N; Koivunen P; Karihtala P; Vuoristo J; Turpeenniemi-Hujanen T; Kuittinen O
Carcinogenesis; 2017 Aug; 38(8):812-820. PubMed ID: 28854563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
